Fundz
You are reading one round. Fundz also knows which of your own LinkedIn connections can open this account.See it live →

TuHURA Biosciences Secures $650,000 Loan to Support Operations

PRIVATESep 14, 20264 days ago

Amount Raised

$650,000

Round Type

Debt Financing

TampaBiotechnologyHealth CareTherapeutics

Investors

Parkview Holdings One Llc

Description

On September 14, 2026, TuHURA Biosciences, Inc. borrowed an additional $650,000 under a revolving credit facility with Parkview Holdings One LLC. The company plans to utilize these funds for general corporate purposes. This funding bolsters TuHURA's financial resources as it continues its developmental initiatives.

Company Information

Company

TuHURA Biosciences

Location

10500 University Center Drive

Tampa, Florida, United States

About

Morphogenesis, Inc. Announces Corporate Rebranding to TuHURA Biosciences, Inc. TuHURA Biosciences, Inc. is a Phase 3 registration-stage immuno-oncology company developing novel technologies to overcome resistance to cancer immunotherapy. The Company’s technologies are designed to overcome primary and acquired resistance to checkpoint inhibitors or cellular therapies in the treatment of cancer.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment TuHURA Biosciences raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Trusted by

OracleSnowflakeCloudflareLinkedInGoogleSalesforce
4.8/5 on G2· Since 2015

Related People

3 contacts
Verified contactsIan F., Senior Research Scientist hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for TuHURA Biosciences's next move

See what Strategic adds

Funding Insights

Based on industry data
VC-backed spending patterns
VC-backed companies spend 89% more on sales and 100% more on marketing than bootstrapped peers
Tech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech

TuHURA Biosciences raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 285,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.